ARTG Entry

KISQALI

ARTG entry for KISQALI (ribociclib), ARTG 280246 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: Novartis Pharmaceuticals
• Active ingredient: ribociclib
• Therapeutic area: Oncology

TGA Public Summary — ARTG 280246